Clifford A. Hudis, MD: The Value of Progression-Free Survival (PFS)

vitaloptions has 475 videos Subscribe Here

Description: Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS). This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium.

Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill-Cornell Medical College in New York City.
Shared By : vitaloptions
Posted on : 01/19/12
Added : 6 years ago
Category : Breast Cancer

More From vitaloptions

Nothing found.